Respiratory Disposables Market

By Type;

Masks, Tubes, Inhalers, and Others

By Disease Indications;

Asthma, Chronic Obstructive Pulmonary Disorder, Tuberculosis, Lung Cancer, and Other Chronic Respiratory Diseases

By End User;

Hospitals, Clinics, Ambulatory Care Centers, and Others

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn819474374 Published Date: August, 2025

Respiratory Disposables Market Overview

Respiratory Disposables Market (USD Million)

Respiratory Disposables Market was valued at USD 1,551.03 million in the year 2024. The size of this market is expected to increase to USD 2,548.20 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.4%.


Respiratory Disposables Market

*Market size in USD million

CAGR 7.4 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.4 %
Market Size (2024)USD 1,551.03 Million
Market Size (2031)USD 2,548.20 Million
Market ConcentrationMedium
Report Pages336
1,551.03
2024
2,548.20
2031

Major Players

  • Medtronic plc
  • ResMed Inc.
  • Fisher & Paykel Healthcare Limited
  • Philips Respironics (a subsidiary of Philips)
  • Smiths Medical (a subsidiary of Smiths Group plc)
  • Teleflex Incorporated
  • Ambu A/S
  • BD (Becton, Dickinson and Company)
  • Vyaire Medical Inc.
  • Drive DeVilbiss Healthcare

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Respiratory Disposables Market

Fragmented - Highly competitive market without dominant players


The Respiratory Disposables Market is rapidly expanding due to increasing cases of chronic respiratory diseases like COPD, asthma, and acute respiratory infections. Roughly 60% of patients depend on single-use devices for effective treatment and hygiene. Rising awareness about respiratory health and preventive care is boosting adoption. Hospitals and clinics are prioritizing cost-effective, high-quality disposable solutions to enhance patient safety.

Technological Advancements
Innovative disposable respiratory devices including masks, nebulizers, oxygen kits, and tubing sets are improving care standards. Around 55% of healthcare providers integrate these solutions to minimize contamination risks. The products offer efficient oxygen delivery, better infection control, and improved patient outcomes. Continuous innovation supports healthcare professionals in meeting complex respiratory needs.

Patient Safety and Hygiene
The emphasis on infection control, particularly in ICUs and respiratory wards, has driven disposable adoption. Approximately 65% of medical facilities now rely on single-use respiratory consumables to maintain sterile environments. This approach ensures reduced infections, patient confidence, and compliance with stringent healthcare guidelines, highlighting its critical role in respiratory care.

Market Adoption
Use of respiratory disposables is growing across hospital, clinical, and home care settings. About 50% of home care patients prefer disposable oxygen masks and nebulizers for convenience and safety. Supportive home healthcare initiatives, reimbursement policies, and patient education programs are contributing to higher market penetration. This trend reflects the increasing preference for safe, user-friendly respiratory solutions.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Type
    2. Market Snapshot, By Disease Indications
    3. Market Snapshot, By End User
    4. Market Snapshot, By Region
  4. Respiratory Disposables Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Increasing prevalence of respiratory diseases
        2. Growing demand for disposable respiratory products due to infection control measures
      2. Restraints
        1. High cost associated with disposable respiratory products
        2. Concerns regarding environmental impact of disposable products
      3. Opportunities
        1. Technological advancements in disposable respiratory products
        2. Emerging markets with untapped potential for respiratory disposables
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Respiratory Disposables Market, By Type, 2021 - 2031 (USD Million)
      1. Masks
      2. Tubes
      3. Inhalers
      4. Others
    2. Respiratory Disposables Market, By Disease Indications, 2021 - 2031 (USD Million)
      1. Asthma
      2. Chronic Obstructive Pulmonary Disorder
      3. Tuberculosis
      4. Lung Cancer
      5. Other Chronic Respiratory Diseases
    3. Respiratory Disposables Market, By End User, 2021 - 2031 (USD Million)
      1. Hospitals
      2. Clinics
      3. Ambulatory Care Centers
      4. Others
    4. Respiratory Disposables Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic plc
      2. ResMed Inc.
      3. Fisher & Paykel Healthcare Limited
      4. Philips Respironics (a subsidiary of Philips)
      5. Smiths Medical (a subsidiary of Smiths Group plc)
      6. Teleflex Incorporated
      7. Ambu A/S
      8. BD (Becton, Dickinson and Company)
      9. Vyaire Medical Inc.
      10. Drive DeVilbiss Healthcare
  7. Analyst Views
  8. Future Outlook of the Market